Significance of p53 expression in gastrointestinal stromal tumors

被引:0
作者
Yalcinkaya, Ulviye [1 ]
Yerci, Omer [1 ]
Koc, Ebru Uzun [1 ]
机构
[1] Uludag Univ, Fac Med, Dept Surg Pathol, Bursa, Turkey
关键词
gastrointestinal stromal tumors; p53; expression; prognosis;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Gastrointestinal stromal tumors are non-epithelial tumors originating from the gastrointestinal tract walls. They expose a wide spectrum of histological properties from benign to poorly differentiated malignant tumors. Methodology: In this study 41 cases of gastrointestinal stromal tumors were reviewed for p53 expression using immunohistochemical stains. Immunoreactivity properties of the tumors were compared to prognostic factors such as mitotic index, tumor size, tumor site, presence of necrosis, mucosal invasion, proliferative index, telomerase activity, hemorrhage, cellularity, and histological pattern. Results: There was a significant difference in positive immunostaining of three case groups (12.2% in benign, 19.5% in borderline, and 68.3% in malignant group). Statistical analysis revealed a statistically significant positive correlation between p53 immunostaining properties and tumor size (p=0.01), mitotic index (p=0.05), cellularity (p=0.042), and diagnosis (p=0.01). Conclusions: We conclude that p53 expression may be a useful tool in classifying and predicting the prognosis of gastrointestinal stromal tumors as it is well correlated with tumor size, mitotic index, cellularity, and diagnosis according to our study results.
引用
收藏
页码:140 / 143
页数:4
相关论文
共 26 条
  • [1] p53 expression in gastrointestinal stromal tumors
    Al-Bozom, IA
    [J]. PATHOLOGY INTERNATIONAL, 2001, 51 (07) : 519 - 523
  • [2] PROGNOSTIC VALUE OF PROLIFERATING CELL NUCLEAR ANTIGEN INDEX IN GASTRIC STROMAL TUMORS - CORRELATION WITH MITOTIC COUNT AND CLINICAL OUTCOME
    AMIN, MB
    MA, CK
    LINDEN, MD
    KUBUS, JJ
    ZARBO, RJ
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (04) : 428 - 432
  • [3] Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining
    Changchien, CR
    Wu, MC
    Tasi, WS
    Tang, R
    Chiang, JM
    Chen, JS
    Huang, SF
    Wang, JY
    Yeh, CY
    [J]. DISEASES OF THE COLON & RECTUM, 2004, 47 (11) : 1922 - 1929
  • [4] KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size
    Corless, CL
    McGreevey, L
    Haley, A
    Town, A
    Heinrich, MC
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (05) : 1567 - 1572
  • [5] Molecular biology of gastric cancer
    El-Rifai, W
    Powell, SM
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (02) : 128 - 140
  • [6] Prognosis of gastrointestinal smooth-muscle (Stromal) tumors - Dependence on anatomic site
    Emory, TS
    Sobin, LH
    Lukes, L
    Lee, DH
    O'Leary, TJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (01) : 82 - 87
  • [7] DIFFERENTIATION AND RISK ASSESSMENT OF GASTROINTESTINAL STROMAL TUMORS
    FRANQUEMONT, DW
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1995, 103 (01) : 41 - 47
  • [8] HIROTA S, 2000, INT J CLIN ONCOL, V6, P1
  • [9] Kim CJ, 2001, AM SURGEON, V67, P135
  • [10] Surgical management of gastrointestinal stromal tumors of the stomach
    Knoop, M
    St Friedrichs, K
    Dierschke, J
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2000, 385 (03) : 194 - 198